Bellido Virginia, Pérez Antonio
Endocrinology and Nutrition Department, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Endocrinology and Nutrition Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Bio-Mèdica Sant Pau, 08041 Barcelona, Spain.
J Clin Med. 2021 Nov 16;10(22):5341. doi: 10.3390/jcm10225341.
Diabetes mellitus (DM) is one of the most common comorbid conditions in persons with COVID-19 and a risk factor for poor prognosis. The reasons why COVID-19 is more severe in persons with DM are currently unknown although the scarce data available on patients with DM hospitalized because of COVID-19 show that glycemic control is inadequate. The fact that patients with COVID-19 are usually cared for by health professionals with limited experience in the management of diabetes and the need to prevent exposure to the virus may also be obstacles to glycemic control in patients with COVID-19. Effective clinical care should consider various aspects, including screening for the disease in at-risk persons, education, and monitoring of control and complications. We examine the effect of COVID-19 on DM in terms of glycemic control and the restrictions arising from the pandemic and assess management of diabetes and drug therapy in various scenarios, taking into account factors such as physical exercise, diet, blood glucose monitoring, and pharmacological treatment. Specific attention is given to patients who have been admitted to hospital and critically ill patients. Finally, we consider the role of telemedicine in the management of DM patients with COVID-19 during the pandemic and in the future.
糖尿病（DM）是2019冠状病毒病（COVID-19）患者中最常见的合并症之一，也是预后不良的危险因素。尽管因COVID-19住院的糖尿病患者的现有数据稀少，但显示血糖控制不佳，目前尚不清楚COVID-19在糖尿病患者中病情更严重的原因。COVID-19患者通常由糖尿病管理经验有限的医护人员护理，以及需要防止接触病毒，这也可能是COVID-19患者血糖控制的障碍。有效的临床护理应考虑多个方面，包括对高危人群进行疾病筛查、教育以及对控制情况和并发症进行监测。我们从血糖控制以及疫情带来的限制方面研究COVID-19对糖尿病的影响，并评估在各种情况下糖尿病的管理和药物治疗，同时考虑体育锻炼、饮食、血糖监测和药物治疗等因素。特别关注住院患者和重症患者。最后，我们考虑远程医疗在疫情期间及未来对COVID-19糖尿病患者管理中的作用。
